These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24325938)

  • 61. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L
    J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Under pressure: predicting pressurized metered dose inhaler interactions using the atomic force microscope.
    Young PM; Price R; Lewis D; Edge S; Traini D
    J Colloid Interface Sci; 2003 Jun; 262(1):298-302. PubMed ID: 16256608
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ProAir(®) HFA delivers warmer, lower-impact, longer-duration plumes containing higher fine particle dose than Ventolin(®) HFA.
    McCabe JC; Koppenhagen F; Blair J; Zeng XM
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):104-9. PubMed ID: 22191397
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Short-term growth and adrenal function in children with asthma treated with inhaled beclomethasone dipropionate hydrofluoroalkane-134a.
    Wolthers OD
    Pediatr Allergy Immunol; 2006 Dec; 17(8):613-9. PubMed ID: 17121590
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel method for the determination of solubility in aerosol propellants.
    Gupta A; Myrdal PB
    J Pharm Sci; 2004 Oct; 93(10):2411-9. PubMed ID: 15349951
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles.
    Chokshi U; Selvam P; Porcar L; da Rocha SR
    Int J Pharm; 2009 Mar; 369(1-2):176-84. PubMed ID: 19028557
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Hydrofluoroalkane as a propellant for pressurized metered-dose inhalers: history, pulmonary deposition, pharmacokinetics, efficacy and safety].
    Ibiapina CC; Cruz AA; Camargos PA
    J Pediatr (Rio J); 2004; 80(6):441-6. PubMed ID: 15622419
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of molecular weight and end-group nature on the solubility of ethylene oxide oligomers in 2H, 3H-decafluoropentane and its fully fluorinated analogue, perfluoropentane.
    Cote M; Rogueda PG; Griffiths PC
    J Pharm Pharmacol; 2008 May; 60(5):593-9. PubMed ID: 18416935
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays.
    Reid ML; Benaouda F; Khengar R; Jones SA; Brown MB
    Int J Pharm; 2013 Aug; 452(1-2):157-65. PubMed ID: 23684656
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
    Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
    [TBL] [Abstract][Full Text] [Related]  

  • 75. How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers.
    Akhuemokhan P; Green NA; Haddrell A; Lewis D; Reid JP; Forbes B
    Int J Pharm; 2023 Mar; 634():122676. PubMed ID: 36738807
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A novel apparatus for the determination of solubility in pressurized metered dose inhalers.
    Traini D; Young PM; Price R; Rogueda P
    Drug Dev Ind Pharm; 2006; 32(10):1159-63. PubMed ID: 17090438
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of hydrofluoroalkane propellant delivery system for inhaled albuterol in patients receiving asthma medications.
    Boccuzzi SJ; Wogen J; Roehm JB
    Clin Ther; 2000 Feb; 22(2):237-47. PubMed ID: 10743983
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Progress of research on pressurized metered dose inhalers].
    Zhou X
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147
    [No Abstract]   [Full Text] [Related]  

  • 79. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
    Selvam P; El-Sherbiny IM; Smyth HD
    J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers.
    Chierici V; Cavalieri L; Piraino A; Paleari D; Quarta E; Sonvico F; Melani AS; Buttini F
    Expert Opin Drug Deliv; 2020 Jul; 17(7):1025-1039. PubMed ID: 32551990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.